Mid-Morning Look: July 22, 2022

Auto PostDaily Market Report

Mid-Morning Look

Friday, July 22, 2022

Index

Up/Down

%

Last

 

DJ Industrials

55.83

0.17%

32,092

S&P 500

-3.40

0.09%

3,995

Nasdaq

-70.07

0.58%

11,989

Russell 2000

-11.60

0.63%

1,825

 

 

Stocks mixed in volatile trading. The massive “risk-on” appetite continued initially with stock markets jumping on the open as major averages look to close out a stellar week much higher than where it started. However, a dire manufacturing report at 9:45 subdued the mood if you will, after U.S. PMI manufacturing data crashed into contraction territory in July, raising fears of a deterioration in the economy. July U.S. PMI Composite Index (Flash) was 47.5 vs. 51.2 in June; and Services PMI down at 47.0 vs. 52.6 expected and 52.7 previously. Following the data, Treasury yields dumped further (were already down prior), with the 10-yr hitting lows below 2.74%, falling over 16-bps before paring losses, while remains inverted against the 2-yr, which was down -13 bps t0 2.96%. The dollar dropped as well, lifting commodity prices including precious metals. Markets in a conundrum, as the Fed is still expected to raise rates by 75-bps next week (lower odds for 100-bps), but odds for more aggressive hikes in September have pared back given the recent downturn in economic data. Overall, not a great morning for earnings with disappointing earnings/guidance from SNAP, TWTR in social media, VZ in Telecom (after AT&T lower guide yesterday), STX in chip space, SAM in beverages, SIVB in banking, COF in cards, ISRG in MedTech – but was offset by better spending/outlook from AXP in credit cards and better hospital results (HCA THC). Next week the busiest week of quarter for S&P earnings.

 

U.S. stocks came into today at 6-week highs, with the S&P 500 topping the 4,000 level after topping its 50-day MA of 3,922 earlier this week, the Nasdaq reclaiming the 12,000 level this week (up 9.4% for July so far, its best month since Nov 2020) and general upward momentum this week. Coming into today, the S&P 500 is up 3.5% WTD, the Dow +2.4%, the Russell 2000 +5.2% and the Nasdaq +5.3%, led by a whopping 8.2% gain in the semiconductor index.

 

Economic Data

·     Much weaker data, raising expectations the Fed will ease back on aggressive rate hikes: July U.S. PMI Composite Index (Flash): 47.5 vs. 51.2 in June; Manufacturing PMI: 52.3 vs. 52.0 expected and 52.7 prior; Services PMI: 47.0 vs. 52.6 expected and 52.7 previously

 

 

Macro

Up/Down

Last

 

WTI Crude

0.06

96.41

Brent

0.94

104.80

Gold

15.0

1,730.20

EUR/USD

0.0008

1.0235

JPY/USD

-1.31

136.05

10-Year Note

-0.108

2.80%

 

 

Sector Movers Today

·     Internet movers: SNAP tumbles 30% after a top and bottom line miss for Q2 and said it is not issuing guidance for Q3 growing just +13% y/y, the lowest on record – Adjusted Ebitda fell -94% y/y to $7.19M, while daily active users of 347M did beat the 343.2M estimate (shares of TWTR, SPOT, META, GOOGL among names falling in sympathy initially); TWTR misses quarterly results as Adj EPS loss was ($-0.08) vs. est. $0.13 on revs $1.18B vs. est. $1.319B and ad revenue $1.08B below est. $1.23B with Q2 Average Monetizable DAU 237.8M vs. est. 237.5M; Barron’s speculated that GOOGL and AMZN could replace DOW and TRV in the Dow Jones Industrial Average after their respective recent stock splits.

·     In Chemicals; SMG was downgraded from Buy to Neutral wat UBS and cut tgt to $92 from $125 as believe limited top/bottom line recovery coupled with a levered balance sheet will keep shares range bound until the next lawn & garden season; in coatings, PPG 2Q EPS $1.81 vs est. $1.73 on revs $4.7B vs est. $4.6B; guides 3Q adj EPS $1.75-2.00 vs est. $2.05 with aggregate sales volumes flat to down low-single-digit %

·     Consumer Finance; COF reported higher revenue and net income slightly above analysts’ expectations for Q2 but EPS of $4.96 missed the $5.09 analyst estimate and non-interest income fell short of analysts’ expectations as well $1.72B vs. $1.75B est. (follows weaker results from DFS the day prior); DFS downgraded to Underweight at Citigroup due to increased uncertainty surrounding its newly announced independent internal investigation into its student loan servicing practices; AXP raises FY rev outlook to +23% to +25% up from prior +18% to +20% after better Q2 revs of $13.4B vs. est. $12.51B while reaffirms EPS views – said revs driven in large part by travel and entertainment spending returning to pre-pandemic levels – still boosted its reserve for credit losses by $410 million

·     Pharma movers; AUPH reported a positive CHMP opinion for Lupkynis (voclosporin) for the treatment of adults with active lupus nephritis in Europe; VRTX advances VX-548 in acute and neuropathic pain into pivotal development for people with acute pain; Phase 3 program to initiate in Q4 2022 – Phase 2 dose-ranging trial in neuropathic pain expected to initiate by year end; VTGN said its experimental drug, PH94B, failed to meet the main goal in a late-stage trial

 

Stock GAINERS

·     AUPH +2%; after the company reported a positive CHMP opinion for Lupkynis (voclosporin) for the treatment of adults with active lupus nephritis in Europe.

·     AXP +4%; raises FY rev outlook to +23% to +25% up from prior +18% to +20% after better Q2 revs of $13.4B vs. est. $12.51B while reaffirms EPS views

·     HCA +13%; beats revenue estimates for the second straight quarter, with revenue of $14.82B above $14.7B estimate and posts Q2 profit beat of $4.21 vs. est. $3.90

·     SLB +6%; reported a top and bottom-line beat ($0.50 vs. est. $0.40 and revs $6.8B vs. est. $6.28B) as logged higher revenue in both its international and North American markets, driven by higher activity and improved pricing

·     THC +9%; posted mixed qtrly results as EPS beat ($1.50 vs. est. $0.82) while revs fell short of consensus but issues year guidance where the mid-point is above views $5.80-$7.00 vs. est. $6.15

 

Stock LAGGARDS

·     APPS, PUBM, TBLA, TTD; as tech names decline following the SNAP results on ad spending slowdown concerns

·     COF -5%; reported higher revenue and net income slightly above analysts’ expectations for Q2 but EPS of $4.96 missed the $5.09 analyst estimate – non-interest income fell short of analysts’ expectations as well

·     CRSR -3%; issued preliminary results for 2Q, missing expectations as sees Q4 revenue $284M vs. est. $348.9M and sees Q4 adjusted EBITDA loss of $10M to $11M

·     ISRG -3%; after a top and bottom-line miss (2Q adj EPS $1.14 vs est. $1.19 on revs $1.52B vs est. $1.56B and placed 279 Da Vinci surgical systems, a decrease of 15% compared with 328 y/y

·     MU -2%; downgraded to Underweight at Morgan Stanley saying they are seeing material volume weakness in all markets, including hyperscale (also hurt by STX guidance)

·     SAM -8%; as Q2 EPS $4.31 vs. est. $4.43 on weaker margins and cuts FY22 adjusted EPS view to $6.00-$11.00 from $11.00-$16.00 (est. $11.67)

·     SIVB -16%; on Q2 EPS miss ($5.60 vs. est. $7.68), while its provision for credit losses rises to $196M vs. $35M a year ago

·     SNAP -35%; downgraded by at least 7-analysts after a top and bottom line miss for Q2 and said it is not issuing guidance for Q3 growing just +13% y/y, the lowest on record

·     STX -5%; Q4 adj EPS $1.59 below consensus $1.88 and revs $2.63B vs. est. $2.78B while guides Q1 EPS $1.20-$1.60 below est. $2.27 and revs $2.35B-$2.65B also well below consensus $3.03B – shares of peer HDD maker WDC falls in sympathy

·     VZ -6%; posted mostly in-line top/bottom line results though sub adds and guidance disappoint – adds 12,000 net phone subscribers, below Street est. of 150,800 additions while lowers 2022 EPS view to $5.10-$5.25 from prior $5.40-$5.55 view and lowers wireless rev growth view as well

_________________________________________________________________

Market commentary provided by Hammerstone Markets, Inc, a firm separate from and not affiliated with Regal Securities. Regal Securities has not participated in the creation of the content, and does not explicitly or implicitly endorse the content.

Live Trading

Open an Account

Paper Trading

Register